This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore innovative ways to get paid instantly without needing a traditional job. These options can provide quick financial relief.
20,854 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Celo Foundation is awarding Opera a one-time grant of 160 million CELO tokens to strengthen its long-term Web3 strate...
Grayscale filed with the SEC to launch the HYPE ETF, which would trade on Nasdaq under GHYP if approved. The fund wou...
When Medicare Part B premiums topped the $200 mark, many retirees felt the impact in real time. This guide explains w...
Long-term wealth isn’t built on quick trades. It comes from steady income and durable growth. Here are two monster di...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Curious about whether Blue Owl Capital can outperform the market? This guide breaks down what to watch, how to analyz...
A bipartisan white paper proposes capping high Social Security payouts to extend the program’s solvency. The measure ...
Spirit Airlines faced a swift collapse amid fuel shocks and regulatory headwinds, sparking questions about who really...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
A targeted Florida housing bill aims to convert idle Southeast Florida golf courses into housing, triggering lawsuits...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...